Review Article
Volume 9 Issue 7 - 2020
Can We Consider All the Cases of COPD Associated with COVID-19 Suffer from Acute Respiratory Failure?
Hatem Fawzi Gharour1,Adem M Mussa El Barghaty2, Abdelhamid El-Zawawi3, Saleh Saeid Muftah4, FG Dawoodi5, Sunny Dawoodi6, Aaren Vedangi7, Shakila Srikumar8, Prajna Barke9, Laxmi Teja Peela10, Nischal Yedla10, Sudheshna Sai Chanamallu10 and Peela Jagannadha Rao11*
1Department of Biochemistry, Faculty of Medicine, University of Benghazi, Benghazi, Libya
2Department of Ophthalmology, Faculty of Medicine, University of Benghazi, Benghazi, Libya
3Department of Medicine, Faculty of Medicine, University of Benghazi, Benghazi, Libya
4Department of Histology, Faculty of Medicine, University of Benghazi, Benghazi, Libya
5Department of Anesthesia, Faculty of Medicine, Quest International University Perak, Ipoh, Malaysia
6Department of Anesthesia, Raja Isteri Pengiran Anak Saleha (RIPAS) Hospital, Brunei
7Clinical Research Scientist and Genetic Consultant, KIMS ICON Hospital, Sheela Nagar, Visakhapatnam, India
8Department of Biochemistry, Faculty of Medicine, Quest International University Perak, Ipoh, Malaysia
9Department of Physiology, School of Medicine, St Matthews University, Grand Cayman, Cayman Islands
10Independent Researcher, Visakhapatnam, AP, India
11Department of Biochemistry and Genetics, School of Medicine, St Matthews University, Grand Cayman, Cayman Islands
*Corresponding Author: Peela Jagannadha Rao, Department of Biochemistry and Genetics, School of Medicine, St Matthews University, Grand Cayman, Cayman Islands.
Received: June 12, 2020; Published: July 08, 2020




Abstract

Chronic obstructive pulmonary disease (COPD) is the third driving reason for death around the world. While COPD is a respiratory illness having various aetiologies especially ceaseless infection, a considerable number of patients experience the ill effects of exacerbation. Extreme exacerbation is identified with an altogether more regrettable result. This survey sums up the present information on the various parts of COPD exacerbations and acute respiratory failure in COPD patients with COVID-19. The effect of hazardous factors and triggers, for example, smoking, extreme wind current restriction, bronchiectasis, bacterial and viral contaminations, and comorbidities is talked about. Increasingly serious exacerbations ought to be treated with β-agonists and anticholinergics just as foundational corticosteroids. Anti-microbial treatment should just be given to patients with assumed bacterial contamination. Non-invasive ventilation is demonstrated in patients with respiratory disappointment. Treatment of hypoxemia and hypercapnia lessen the pace of COPD intensifications.

In December 2019, a flare-up of coronavirus disease 2019 (COVID-19) was recognized in Wuhan, China. The World Health Organization (WHO) pronounced this episode a noteworthy danger to worldwide wellbeing. COVID-19 is exceptionally irresistible and can prompt lethal comorbidities particularly in chronic obstructive pulmonary disease (COPD) patients. Consequently, completely understanding the qualities of COVID-19 in patients with (COPD) is helpful for early distinguishing proof and appropriate treatment. The clinical indications were generally mellow in some COVID-19 patients, which was conflicting with the seriousness of research facility and imaging discoveries. The seriousness was re-imagined into three phases as per its particularity: gentle, mellow moderate, and moderate-extreme. The almost certain reason for death is serious respiratory failure. Along these lines, the planning of intrusive mechanical ventilation is significant. The impacts of corticosteroids in COVID-19-(COPD) patients were helpful to some point. 

Keywords: COPD (Chronic Obstructive Pulmonary Disease); COVID-19

References

  1. Vestbo J., et al. “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 1. GOLD executive summary”. American Journal of Respiratory and Critical Care Medicine 4 (2013): 347-365.
  2. Román Sánchez P., et al. “Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease”. Thorax 60 (2005): 925-931.
  3. Martinez FJ., et al. “Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD executive summary”. European Respiratory Journal 49 (2017): 1700214.
  4. Albert RK., et al. “Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline”. European Respiratory Journal 50 (2017): 1602265.
  5. Van Le H., et al. “Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study”. PLoS One 9 (2014): e97149.
  6. Anzueto A., et al. “Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease”. Journal of Infection 67 (2013): 497-515.
  7. Köhler D., et al. “Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomized, controlled clinical trial”. The Lancet Respiratory Medicine 2 (2014): 698-705.
  8. Strange C., et al. “Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial”. The Journal of the American Medical Association 315 (2016): 2178-2189.
  9. World Health Organization. “Coronavirus disease (COVID-19)” (2020).
  10. Lippi G and Henry BM. “Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019”. Research Medicine (2020).
  11. Guan WJ., et al. “Clinical characteristics of coronavirus disease 2019 in China”. The New England Journal of Medicine (2020).
  12. Phan LT., et al. “Importation and human-to-human transmission of a novel coronavirus in Vietnam”. The New England Journal of Medicine 9 (2020): 872-874.
  13. Chen N., et al. “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study”. Lancet 10223 (2020): 507.
  14. Jeffery PK. “Differences and similarities between chronic obstructive pulmonary disease and asthma”. Clinical and Experimental Allergy 29 (1999): 14-26.
  15. Chung M., et al. “CT imaging features of 2019 novel coronavirus (2019-nCoV)”. Radiology 1 (2020): 202-207.
  16. Ranieri VM., et al. “Acute respiratory distress syndrome: the Berlin definition”. The Journal of the American Medical Association 307 (2012): 2526-2533.
  17. Donaldson GC., et al. “Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease”. Thorax10 (2002): 847-852.
  18. Soler-Cataluña JJ., et al. “Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease”. Thorax 11 (2005): 925-931.
  19. West JB. “Causes of and compensations for hypoxemia and hypercapnia”. Comprehensive Physiology 3 (2011): 1541-1553.
  20. Quintana JM., et al. “Predictive score for mortality in patients with COPD exacerbations attending hospital emergency departments”. BMC Medicine 12 (2014): 66.
  21. Barberà JA., et al. “Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease”. European Respiratory Journal 6 (1997):1285-1291.
  22. Ou X., et al. “Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials”. Canadian Medical Association Journal 189 (2017): E260-E267.
  23. Meduri GU., et al. “Prolonged low-dose methylprednisolone treatment is highly effective in reducing the duration of mechanical ventilation and mortality in patients with ARDS”. Journal of Intensive Care Medicine 6 (2018): 53.
  24. Wang D., et al. “Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China”. The Journal of the American Medical Association (2020).
  25. Huang C., et al. “Clinical features of patients with 2019 novel coronavirus in Wuhan, China”. Lancet 10223 (2020): 497-506.
  26. Xu Z., et al. “Pathological findings of COVID-19 associated with acute respiratory distress syndrome”. The Lancet Respiratory Medicine (2020).
  27. World Health Organization. “Clinical Management of Severe Acute Respiratory Infection when CoViD-19 Is Suspected” (2020).
  28. Zhou P., et al. “A pneumonia outbreak associated with a new coronavirus of probable bat origin”. Nature7789 (2020): 270-273.
  29. Jackson DJ and Johnston SL. “The role of viruses in acute exacerbations of asthma”. The Journal of Allergy and Clinical Immunology 6 (2010): 1178-1189.
  30. Mohan A., et al. “Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review”. Respirology 3 (2010): 536-542.
  31. Proud D and Chow CW. “Role of viral infections in asthma and chronic obstructive pulmonary disease”. American Journal of Respiratory Cell and Molecular Biology 5 (2006): 513‐518.
  32. Global Initiative for Chronic Obstructive Lung Disease (Gold) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020).
  33. Calzetta L., et al. “Withdrawal of inhaled corticosteroids in COPD: a meta-analysis”. Pulmonary Pharmacology and Therapeutics 45 (2017): 148-158.
  34. Alía I., et al. “Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support”. Archives of Internal Medicine 21 (2011): 1939-1946.
  35. Jackson DJ and Johnston SL. “The role of viruses in acute exacerbations of asthma”. The Journal of Allergy and Clinical Immunology 6 (2010): 1178-1189.
  36. Kaiser UB., et al. “Our response to COVID-19 as endocrinologists and diabetologists”. The Journal of Clinical Endocrinology and Metabolism 5 (2020): dgaa148.
  37. Wu C., et al. “Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China”. JAMA Internal Medicine (2020).
Citation: Hatem Fawzi Gharour., et al. ““Can We Consider All the Cases of COPD Associated with COVID-19 Suffer from Acute Respiratory Failure?”. EC Pulmonology and Respiratory Medicine 9.8 (2020): 11-16.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for January Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the January issue of respective journals. Submissions are accepted on/before December 03, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk